A second pivotal trial of piclidenoson for the treatment of rheumatoid arthritis

Trial Profile

A second pivotal trial of piclidenoson for the treatment of rheumatoid arthritis

Planning
Phase of Trial: Phase III

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs Piclidenoson (Primary)
  • Indications Rheumatoid arthritis
  • Focus Registrational; Therapeutic Use
  • Acronyms ACROBAT
  • Most Recent Events

    • 07 Aug 2017 According to a Can-Fite BioPharma media release, this trial is expected to initiate in 2017.
    • 07 Aug 2017 According to a Can-Fite BioPharma media release, based on the favorable safety data from cardiodynamic trial CTP#700287672 company is cleared to initiate this study.
    • 07 Nov 2016 According to a Can-Fite BioPharma media release, protocol has recently been agreed with EMA.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top